Methods and Results: The induction of colitis in immunocompromised mice receiving CD4+CD25− T cells i.p. resulted in a moderate inflammation and was met with limited protective responses following daily subcutaneous administration of MR120 or MR452 for 8 weeks. This evidence concerns the gene CD4 and colitis.